ANP 5.26% 20.0¢ antisense therapeutics limited

abno amro say buy

  1. 3,567 Posts.
    Their target is over $0.30 which isn't bad considering the current price is $0.08. Some of their milestones have already been met.

    Here is their report:

    "Source: ABN AMRO Morgans Small Caps
    Antisense Therapeutics is involved in the development and commercialisation of novel Antisense
    drugs which are small DNA-like molecules designed to work by using genetic information directly to
    prevent the production of specific disease causing proteins. By contrast, conventional drugs bind to
    disease causing proteins that have already been produced. Due to their increased specificity of action,
    antisense drugs may have enhanced therapeutic effects without the undesirable side effects of
    conventional therapy. Also, when compared to conventional drug discovery, the use of antisense
    drugs may potentially reduce the risks associated with drug design resulting in faster, more
    predictable drug discovery, with increased specificity of action and uniformity of methods of
    manufacture, formulation and delivery. Antisense drugs have the potential to treat a wide range of
    conditions and diseases. Antisense’s initial focus is on multiple sclerosis and psoriasis.
watchlist Created with Sketch. Add ANP (ASX) to my watchlist
(20min delay)
Mkt cap ! $114.8M
Open High Low Value Volume
19.0¢ 20.3¢ 19.0¢ $243.6K 1.231M

Buyers (Bids)

No. Vol. Price($)
2 156423 20.0¢

Sellers (Offers)

Price($) Vol. No.
20.5¢ 32152 2
View Market Depth
Last trade - 16.10pm 21/04/2021 (20 minute delay) ?
0.010 ( 2.56 %)
Open High Low Volume
19.5¢ 20.0¢ 19.5¢ 330307
Last updated 15.41pm 21/04/2021 (live) ?
ANP (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.